Jalra-DP Tablet SR

Description

About Jalra-DP Tablet SR

Jalra-DP Tablet SR is a combination oral anti-diabetic medicine for adults with Type 2 Diabetes Mellitus.
It is prescribed when diet, exercise, and monotherapy are insufficient to achieve optimal blood glucose control.
The sustained-release (SR) formulation ensures gradual and steady release of the active ingredients, improving fasting and postprandial glucose levels throughout the day.

---

How It Works

• Dapagliflozin (10mg): A SGLT2 inhibitor that helps the kidneys remove excess glucose through urine, lowering blood sugar levels.

• Vildagliptin (100mg): A DPP-4 inhibitor that increases incretin hormones, stimulating insulin secretion after meals and reducing glucagon release.

Together, they provide dual-action glucose control, targeting both renal glucose excretion and pancreatic insulin regulation.

---

Uses

• Management of Type 2 Diabetes Mellitus

• Controls both fasting and postprandial blood glucose levels

• Can be combined with other oral anti-diabetics or insulin as prescribed

---

Directions for Use

• Take once daily, preferably in the morning, with or without food.

• Swallow whole; do not crush or chew.

• Maintain a healthy diet and regular exercise for optimal blood sugar control.

---

Side Effects

Common side effects may include:

• Urinary tract infections (UTIs)

• Increased urination

• Dizziness or headache

• Nausea or stomach upset

• Mild hypoglycemia (more likely when used with sulfonylureas or insulin)

Seek medical attention if you experience severe hypoglycemia, signs of ketoacidosis, or allergic reactions.

---

Precautions

• Inform your doctor if you have kidney, liver, or heart problems.

• Drink plenty of fluids to prevent dehydration.

• Not recommended during pregnancy or breastfeeding unless prescribed.

• Monitor blood glucose and HbA1c levels regularly.

• Take the tablet at the same time each day for consistent glycemic control.